Delivery Order SPE2DR25D1100-SPE2DR26FCS6Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units, with a ceiling value of $10,773.72 and completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,223.24 on August 18, 2025, for the supply of LENVIMA 10 mg daily dose tablets (30-count) under a firm fixed-price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $21,547.44 by the Defense Logistics Agency (DLA) on November 6, 2025, for the supply of LENVIMA 10 mg daily dose in quantities of 30 units. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of December 1, 2025. This award...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count packaging). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by December 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lenvima is a targeted cancer therapy medication, and this...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of Lenvima 18 mg daily dose tablets (90-count package). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 26, 2025, and represents fulfillment under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,547.44 to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose (30-count package) on December 8, 2025. This firm fixed-price contract, with an ultimate completion date of December 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS6YDelivery Order
The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of December 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, maintains an extensive portfolio of federal contract awards covering a comprehensive range of medications and medical supplies. The company's DLA prime contract vehicle enables it to supply pharmaceuticals and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for Lenvima, a specialized oncology medication, exemplifies the company's role in providing critical brand-name therapeutics to federal healthcare programs serving military beneficiaries and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/2/25 |